Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
Fortescue Future Industries
Iron Ore Stocks Mining Stocks
Fortescue Future Industries: Are the iron giant’s bold green ambitions on track?
In 2020, Fortescue Future Industries was born to realise the then-Twiggy Forrest operated iron ore miner's green ambitions, including in hydrogen. It is no longer a standalone brand and is integrated along with Fortescue's broader operations.The question this article looks at is simple: Is Fortescue walking the talk? What are the Best ASX stocks to invest in…
February 20, 20260Comments
ASX company spin
Education Mid Cap Stocks Penny Stocks Small Caps Stocks Undervalued Stocks
ASX Company Spin: Here are 7 occasions when management tries to sell bad news as good news
In all our years, we have seen our fair share of ASX Company Spin. It is repeated because often investors fall for it. Even if not all do, it is sufficient that some investors fall for it to achieve what has to be achieved.For instance, that enough believe a capital raising at a >25% discount…
February 19, 20260Comments
Cisco Systems
International Stocks Tech Stocks Technology
Cisco Systems (NDQ:CSCO): Will this US$300bn company really be a winner from the AI boom? Investors aren’t so sure
As a big company in the networking equipment space, Cisco Systems (NDQ:CSCO) is a company you could be forgiven for thinking will be a winner from AI just by being there. But investor reaction to its latest results suggest investors are currently skeptical. What are the Best ASX stocks to invest in right now? Check our buy/sell…
February 18, 20260Comments
why share prices fall after a capital raising
Biotech Stocks Healthcare Stocks Life Sciences
If you wondered why share prices fall after a capital raising, Botanix is the ‘perfect’ poster child
We thought this was a perfect time to ponder the question,' Why share prices fall after a capital raising', in light of what happened with Botanix Pharmaceuticals (ASX:BOT). Its shares fell 33% in less than an hour of trading. Now, shouldn't investors be happy that the company has $45m more cash? Let's just say that…
February 18, 20260Comments
genetype
Biotech Stocks Healthcare Stocks Life Sciences Small Caps Stocks Undervalued Stocks
Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!
Investors may remember Rhythm Biosciences (ASX:RHY) for its ColoSTAT test, but it is Genetype that is arguably more exciting. The company now has a substantially larger market awaiting us, and while its commercialisation strategy for ColoSTAT has changed, this strategy has been successful.Wait, has Rhythm received TGA approval? Yes and no - it's a long…
February 17, 20260Comments

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here